Torti Frank

President and Vant Chair at Roivant Sciences Ltd. · on record since Apr 2, 2026
Director at Urovant Sciences Ltd. · on record since Sep 26, 2018
Director at Arbutus Biopharma Corp · on record since Nov 27, 2018
Director at Sio Gene Therapies Inc. · on record since Oct 16, 2018
Director at Myovant Sciences Ltd. · on record since Nov 8, 2018
Director at Immunovant, Inc. · on record since Apr 9, 2026

Insider trading activity of Torti Frank

Transactions on record: 53; since Oct 16, 2018

Open-market buys: 1; $116.2K

Open-market sells: 3; $82M

Companies traded: 6; last filing Oct 2, 2026

Figures computed from official regulatory filings — .

Companies where Torti Frank has traded

Roivant Sciences Ltd.17 tx · $106.3M · Oct 2, 2026
Immunovant, Inc.21 tx · $116.2K · Apr 9, 2026
Arbutus Biopharma Corp7 tx · May 24, 2024
Sio Gene Therapies Inc.4 tx · Apr 19, 2021
Myovant Sciences Ltd.2 tx · Aug 27, 2019
Urovant Sciences Ltd.2 tx · Jul 11, 2019

Track record of Torti Frank

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Torti Frank

Co-insiders of Torti Frank

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Roivant Sciences Ltd.Listing on record	Oct 2, 2026	Other	40,309	36.57 USD	$1.5M	SEC
Roivant Sciences Ltd.Listing on record	Jul 2, 2026	Other	-40,310	35.39 USD	$1.4M	SEC
Immunovant, Inc.Listing on record	Apr 9, 2026	Award	174,189	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 9, 2026	AwardD (derivative)	88,325	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Apr 2, 2026	Other	-160,035	27.70 USD	$4.4M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Sell	-1,400,000	27.42 USD	$38.4M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Exercise	1,012,610	3.85 USD	$3.9M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-587,390	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Exercise	587,390	3.85 USD	$2.3M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Sell	-1,012,610	27.15 USD	$27.5M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-1,012,610	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-1,400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Sell	-587,390	27.51 USD	$16.2M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Exercise	1,400,000	3.85 USD	$5.4M	SEC
Roivant Sciences Ltd.Listing on record	Dec 29, 2025	Other	-64,891	22.47 USD	$1.5M	SEC
Roivant Sciences Ltd.Listing on record	Dec 29, 2025	Award	175,380	22.45 USD	$3.9M	SEC
Roivant Sciences Ltd.Listing on record	Dec 29, 2025	Gift	-110,489	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Aug 1, 2025	Award	11,900,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Aug 1, 2025	Award	1,836,547	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 3, 2025	Award	199,365	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 3, 2025	AwardD (derivative)	93,599	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Arbutus Biopharma CorpListing on record	May 24, 2024	AwardD (derivative)	67,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 4, 2024	Award	120,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 4, 2024	AwardD (derivative)	50,167	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Arbutus Biopharma CorpListing on record	May 26, 2023	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Roivant Sciences Ltd.Listing on record	Oct 2, 2026	Other	40,309	36.57 USD	$1.5M	SEC
Roivant Sciences Ltd.Listing on record	Jul 2, 2026	Other	-40,310	35.39 USD	$1.4M	SEC
Immunovant, Inc.Listing on record	Apr 9, 2026	Award	174,189	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 9, 2026	AwardD (derivative)	88,325	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Apr 2, 2026	Other	-160,035	27.70 USD	$4.4M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Sell	-1,400,000	27.42 USD	$38.4M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Exercise	1,012,610	3.85 USD	$3.9M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-587,390	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Exercise	587,390	3.85 USD	$2.3M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Sell	-1,012,610	27.15 USD	$27.5M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-1,012,610	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-1,400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Sell	-587,390	27.51 USD	$16.2M	SEC
Roivant Sciences Ltd.Listing on record	Feb 23, 2026	Exercise	1,400,000	3.85 USD	$5.4M	SEC
Roivant Sciences Ltd.Listing on record	Dec 29, 2025	Other	-64,891	22.47 USD	$1.5M	SEC
Roivant Sciences Ltd.Listing on record	Dec 29, 2025	Award	175,380	22.45 USD	$3.9M	SEC
Roivant Sciences Ltd.Listing on record	Dec 29, 2025	Gift	-110,489	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Aug 1, 2025	Award	11,900,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Roivant Sciences Ltd.Listing on record	Aug 1, 2025	Award	1,836,547	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 3, 2025	Award	199,365	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 3, 2025	AwardD (derivative)	93,599	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Arbutus Biopharma CorpListing on record	May 24, 2024	AwardD (derivative)	67,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 4, 2024	Award	120,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Immunovant, Inc.Listing on record	Apr 4, 2024	AwardD (derivative)	50,167	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Arbutus Biopharma CorpListing on record	May 26, 2023	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC